Bayer, Moderna-Backed Metagenomi’s Stock Crashes 31% in Friday IPO Debut

Metagenomi shares dropped 31% on Friday afternoon in a disappointing debut on the Nasdaq Global Select Market, highlighting the potential perils faced by preclinical biotechs seeking to go public, according to Seeking Alpha.